Bismuth subcitrate potassium, metronidazole, and tetracycline and Remifentanil Intravenous
Determining the interaction of Bismuth subcitrate potassium, metronidazole, and tetracycline and Remifentanil Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bismuth subcitrate potassium / metronidazole / tetracycline
Brand name: Pylera
Synonyms: Bismuth Subcitrate, Metronidazole, and Tetracycline
Generic Name: remifentanil
Brand name: Ultiva
Synonyms: Remifentanil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Reminyl
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Reminyl ER
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Remodulin
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Remodulin injection
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Remular-S
- Bismuth subcitrate potassium, metronidazole, and tetracycline-Renacidin
- Remifentanil Intravenous-Bismuth Subcitrate, Metronidazole, and Tetracycline
- Remifentanil Intravenous-Bismuth Subgallate
- Remifentanil Intravenous-Bismuth subsalicylate
- Remifentanil Intravenous-Bismuth Subsalicylate Chewable Tablets
- Remifentanil Intravenous-Bismuth Subsalicylate Suspension
- Remifentanil Intravenous-Bismuth Subsalicylate Tablets